Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV005092611 | SCV001022108 | likely benign | not provided | 2025-01-15 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV000879098 | SCV001527707 | uncertain significance | Combined immunodeficiency due to DOCK8 deficiency | 2018-04-19 | criteria provided, single submitter | clinical testing | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. |
Gene |
RCV002251528 | SCV002522109 | uncertain significance | not provided | 2022-05-19 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Ambry Genetics | RCV004027922 | SCV004859257 | uncertain significance | Inborn genetic diseases | 2023-11-17 | criteria provided, single submitter | clinical testing | The c.4724G>A (p.R1575K) alteration is located in exon 37 (coding exon 37) of the DOCK8 gene. This alteration results from a G to A substitution at nucleotide position 4724, causing the arginine (R) at amino acid position 1575 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |